1-4 of 4
Inger Marie S Dahl
Close
Sort by
Journal Articles

Multiple Myeloma Plasma Cell Expression of Hepatocyte Growth Factor mRNA Isoforms Correlates with Overall Survival In Myeloma Patients

Ida Bruun Kristensen, MD, Jacob Haaber Christensen, MD, PhD, Maria Lyng, MSc, PhD, Tobias W Klausen, MSc, Lene Meldgaard Knudsen, MD, PhD, Inger Marie S Dahl, Thomas Rasmussen, MSc, PhD, Henrik Ditzel, MD, PhD, Niels Abildgaard, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4983.
https://doi.org/10.1182/blood.V116.21.4983.4983
Published: 2010
Journal Articles

Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors

Clinical Trials & Observations
Thomas Rasmussen, Michael Kuehl, Marianne Lodahl, Hans E. Johnsen, Inger Marie S. Dahl
Journal: Blood
Blood (2005) 105 (1): 317–323.
https://doi.org/10.1182/blood-2004-03-0833
Published: 2005
Journal Articles

Serum syndecan-1: a new independent prognostic marker in multiple myeloma

Carina Seidel, Anders Sundan, Martin Hjorth, Ingemar Turesson, Inger Marie S. Dahl, Niels Abildgaard, Anders Waage, Magne Børset
Journal: Blood
Blood (2000) 95 (2): 388–392.
https://doi.org/10.1182/blood.V95.2.388
Published: 2000
Journal Articles

Serum Hyaluronan in Patients With Multiple Myeloma: Correlation With Survival and Ig Concentration

Inger Marie S. Dahl, Ingemar Turesson, Erik Holmberg, Karin Lilja
Journal: Blood
Blood (1999) 93 (12): 4144–4148.
https://doi.org/10.1182/blood.V93.12.4144
Published: 1999